Magdalena Molero (Magdalena Molero-Abraham)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Idiopathic Pulmonary Fibrosis

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Melina Peressini, María Del Rosario García-Campelo, Bartomeu Massuti, Cristina Martí, Manuel Cobo, Vanesa Gutiérrez, Manuel Dómine, Jose Fuentes, Margarita Majem Tarruella, Javier De Castro Carpeño, Juan Felipe Cordoba, Maria Pilar Diz, Dolores Isla, Emilio Esteban, Enric Carcereny, Laia Vila, Alberto Moreno-Vega, Silverio Ros, Amaia Moreno, Francisco Javier Garcia, Gerardo Huidobro, Carlos Aguado, Victor Cebey-Lopez, Javier Valdivia, Ramon Palmero, Pilar Lianes, Marta López-Brea Piqueras, Oscar Juan Vidal, Mariano Provencio Pulla, Edurne Arriola, Javier Baena, Mercedes Herrera-Juárez, Helena Bote, Magdalena Molero, Vera Adradas, Santiago Ponce-Aix, Ángel Nuñez-Buiza, Álvaro C Ucero, Susana Hernandez, Fernando López-Ríos, Esther Conde, Luis G Paz-Ares, Jon Zugazagoitia
Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Anaïs Jiménez-Reinoso, Magdalena Molero, Cristina Cirauqui, Belén Blanco, Eva Maria Garrido-Martin, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Ángel Ramírez-Fernández, Laura Díez-Alonso, Ángel Nuñez-Buiza, África Gónzalez-Murillo, Raquel Tobes, Eduardo Pareja, Manuel Ramírez, José Luis Rodriguez-Peralto, Irene Ferrer, Jon Zugazagoitia, Luis G Paz-Ares, Luis Alvarez-Vallina
CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. Oncoimmunology 13 (1) (2024)
Melina Peressini, María Del Rosario García-Campelo, Bartomeu Massuti, Cristina Martí, Manuel Cobo, Vanesa Gutiérrez, Manuel Dómine, Jose Fuentes, Margarita Majem Tarruella, Javier De Castro Carpeño, Juan Felipe Cordoba, Maria Pilar Diz, Dolores Isla, Emilio Esteban, Enric Carcereny, Laia Vila, Alberto Moreno-Vega, Silverio Ros, Amaia Moreno, Francisco Javier Garcia, Gerardo Huidobro, Carlos Aguado, Victor Cebey-Lopez, Javier Valdivia, Ramon Palmero, Pilar Lianes, Marta López-Brea Piqueras, Oscar Juan Vidal, Mariano Provencio Pulla, Edurne Arriola, Javier Baena, Mercedes Herrera-Juárez, Helena Bote, Magdalena Molero, Vera Adradas, Santiago Ponce-Aix, Ángel Nuñez-Buiza, Álvaro C Ucero, Susana Hernandez, Fernando López-Ríos, Esther Conde, Luis G Paz-Ares, Jon Zugazagoitia
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Anaïs Jiménez-Reinoso, Magdalena Molero, Cristina Cirauqui, Belén Blanco, Eva Maria Garrido-Martin, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso, Ángel Ramírez-Fernández, Laura Díez-Alonso, Ángel Nuñez-Buiza, África Gónzalez-Murillo, Raquel Tobes, Eduardo Pareja, Manuel Ramírez, José Luis Rodriguez-Peralto, Irene Ferrer, Jon Zugazagoitia, Luis G Paz-Ares, Luis Alvarez-Vallina
CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts. Oncoimmunology 13 (1) (2024)
Francisco Expósito, Miriam Redrado, Maeva Houry, Katherine Hastings, Magdalena Molero, Teresa Lozano, José Luis Solórzano, Julián Sanz, Vera Adradas, Ramon Amat, Esther Redin, Sergio Leon, Naroa Legarra, Javier Garcia, Angel Rodriguez, Karmele Valencia, Camila Robles-Oteíza, Giorgia Foggetti, Nerea Otegui, Enriqueta Felip Font, Juan Jose Lasarte, Luis G Paz-Ares, Jon Zugazagoitia, Katerina Politi, Luis M Montuenga, Alfonso Calvo
PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer research (2023)